BCR and B-cell chronic lymphocytic leukemia: Interestingly, the release of MVs in vitro and the release of plasma EXOs after BCR stimulation was greater in CLL cells from patients with a poor prognosis UM-IGHV, even though the difference vs. mutated-IGHV patients was not statistically significant [45,47].